December 2, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that the Company has received clearance from the Food and Drug Administration (FDA) to market the ON-Q SilverSoaker, a unique, proprietary, silver-coated, antimicrobial catheter that will be immediately added to the rapidly growing ON-Q family of products.

December 1, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the First Albany Capital Annual Growth Conference, Tuesday afternoon, December 6, 2005 at 5:20 p.m. EST.

November 23, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the Lazard Capital Markets Annual Life Sciences Conference, Tuesday morning, Novemberember 29, 2005, at 8:30 a.m. EST.

November 22, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that the Company has partnered with the University of Minnesota (U of MN) to conduct an animal study to evaluate the promise of antimicrobial benefits of ON-Q(R). This will replace a previous study launched in June in partnership with Tulane University Health Sciences Center, which was halted abruptly, due to the effects of Hurricane Katrina, before results could be collected.

November 11, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that the ON-Q Post-Operative Pain Relief System was featured in five presentations at the recent American Society of Anesthesiologists (ASA) meeting. The meeting, held in Atlanta this year, has served as a forum for landmark studies conducted by I-Flow since 2002.

October 27, 2005
I-Flow Corporation (NASDAQ:IFLO) today announced a net loss for the third quarter of 2005 of $488,000, or $0.02 per share, substantially improved from a net loss of $1,770,000, or $0.08 per share, for the third quarter of 2004 and a net loss of $645,000, or $0.03 per share, for the second quarter of 2005.

October 24, 2005
I-FLOW CORPORATION (NASDAQ:IFLO) plans to release financial results for the third quarter ended September 30, 2005 at approximately 7:30 a.m. EDT on Thursday, October 27, 2005. I-Flow Corporation has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter.

October 4, 2005
I-Flow Corporation (NASDAQ:IFLO) has launched three unique product packages that deliver the benefits of ON-Q, a targeted post-surgical pain relief system, to a greater number of patients.

September 7, 2005
I-Flow Corporation (NASDAQ:IFLO) recently signed several new contracts with managed care companies to provide reimbursement for the use of ON-Q where appropriate in ambulatory surgery centers (ASC) nationwide.

September 1, 2005
Dr. Timothy Kremchek, medical director and chief orthopaedic surgeon for the Cincinnati Reds, is transforming total knee replacement (TKR), once relegated to the hospital setting, by doing it on an outpatient basis (a 23-hour or less stay).

August 30, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the Roth Capital Partners New York Conference on Wednesday, September 7, 2005 at 1:30 p.m. EDT.

July 28, 2005
I-Flow Corporation (NASDAQ:IFLO) today announced a net loss for the second quarter of 2005 of $645,000, or $0.03 per share, as revenue for the period increased 41% to a record $24,183,000 from $17,167,000 for the second quarter of 2004.

July 25, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that InfuSystem, a wholly-owned subsidiary of I-Flow Corporation and the nationwide leader in ambulatory infusion management services, signed ten new managed care contracts.

July 19, 2005
I-Flow Corporation (NASDAQ:IFLO) has signed four new contracts with insurance companies to provide reimbursement for the use of ON-Q, a targeted post-surgical pain relief system, where appropriate in ambulatory surgery centers (ASC) nationwide.

July 18, 2005
I-FLOW CORPORATION (NASDAQ:IFLO) plans to release financial results for the second quarter ended June 30, 2005 at approximately 7:30 a.m. EDT on Thursday, July 28, 2005. I-Flow Corporation has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter.

Jun 20, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that the Company will partner with Tulane University Health Sciences Center to conduct an animal study to evaluate the antimicrobial benefits of ON-Q(R). If this research yields positive results, this may expand the use of ON-Q beyond today's labeling of significantly reducing pain and narcotics intake after surgery.

June 1, 2005
I-Flow Announces Extension of Common Stock Repurchase Program

May 11, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the Banc of America Securities Health Care Conference on Wednesday afternoon, May 18, 2005 at 2:00 p.m. PDT (5:00 p.m. EDT). The Conference is scheduled for May 17th through May 19th at the Four Seasons Hotel, Las Vegas, Nevada.

April 26, 2005
I-Flow Corporation (NASDAQ:IFLO) announced today that revenue for the first quarter of 2005 increased 60% to $22,741,000, a new all-time high, from $14,169,000 for the first quarter of 2004.

April 22, 2005
I-FLOW CORPORATION (NASDAQ:IFLO) plans to release financial results for the first quarter ended March 31, 2005 at approximately 7:30 a.m. EDT on Tuesday, April 26, 2005. I-Flow Corporation has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter.

April 5, 2005
Donald M. Earhart, I-Flow's Chairman, President and Chief Executive Officer, will make a presentation describing the Company's growth strategies and market opportunities for its Regional Anesthesia business.

March 15, 2005
I-Flow Corporation (NASDAQ: IFLO) today announced that a long-term study on the use of ON-Q(R) PainBuster(R) following breast cancer surgery was presented recently at a major surgical meeting.

March 11, 2005
I-FLOW CORPORATION (NASDAQ:IFLO) announced today that it will address institutional shareholders at the SG Cowen & Co. 25th Annual Health Care Conference, Tuesday morning, March 15, 2005 at 8:50 a.m. EST.

February 22, 2005
I-flow announces 51% increase in 2004 revenue; regional anesthesia sales increased 101%; oncology infusion services increased 49%

February 18, 2005
I-FLOW CORPORATION (NASDAQ:IFLO) plans to release financial results for the fourth quarter and year ended December 31, 2004 at approximately 7:30 a.m. EST on Tuesday, February 22, 2005.

February 17, 2005
The Roth Capital Partners Conference will take place February 22nd and 23rd at the St. Regis Monarch Beach Resort & Spa, Dana Point, California.

February 10, 2005
I-Flow Corporation (NASDAQ: IFLO) today announced that two recently published studies of post-surgical pain relief after hernia surgery will be featured at this week's annual American Hernia Society meeting in San Diego.

February 3, 2005
I-Flow Corporation (NASDAQ: IFLO) today announced contracts with twelve managed care organizations representing HMOs, PPOs, and Workmen's Compensation providers that will begin to routinely reimburse for ON-Q for post-surgical pain relief.

January 26, 2005
I-Flow Corporation (NASDAQ: IFLO) announced today that Dr. Randall K. Wolf, Executive Director of the Center for Surgical InNovemberation at the University of Cincinnati Medical Center, will demonstrate the use of ON-Q PainBuster during a live telesurgery broadcast at the annual meeting of the Society of Thoracic Surgeons in Tampa, Florida.

January 25, 2005
I-Flow Corporation (Nasdaq:IFLO) announced today that it will address institutional shareholders at the Piper Jaffray Healthcare Conference on Wednesday, January 26, at 10:00 a.m. EST (7:00 a.m. PST).

January 13, 2005
I-Flow Corporation (NASDAQ: IFLO) announced today that the U.S. Food and Drug Administration (FDA) has cleared its ten inch ON-Q Soaker(TM) Catheter

January 6, 2005
Presentation at the San Antonio Breast Cancer Symposium Highlights the Benefits of ON-Q to Significantly Reduce Post-Surgical Narcotics Use with Breast Cancer Surgery